Summary:
A 2 part study investigating the effects of TD-9855 for the treatment of orthostatic hypotension due to Parkinsons, multiple system atrophy, or pure autonomic failure.
Qualified Participants Must:
• Be diagnosed with symptomatic orthostatic hypotension due to Parkinson's disease, multiple system atrophy, or pure autonomic failure, (i.e. neurogenic orthostatic hypotension)
•
Be between 40 and 80 years of age
Qualified Participants May Receive:
Compensation for time and travel. Qualified participants may also receive investigational drug at no cost.